September 2026
The multiple sclerosis diagnostics market size was USD 6.20 billion in 2026, with leading multiple sclerosis diagnostics market players including F. Hoffmann-La Roche Ltd., Siemens Healthineers, GE HealthCare, Thermo Fisher Scientific.
September 2026
The global multiple sclerosis therapeutics market size was evaluated at USD 37.16 billion in 2026 and is predicted to hit around USD 66.80 billion by 2035, growing at a CAGR of 6.90%.
June 2026
The U.S. multiple sclerosis drugs market size is estimated to hit around USD 18.43 billion by 2035 increasing from USD 8.44 billion in 2025, with a CAGR of 8.12%.
April 2026
The global multiple sclerosis drugs market size is estimated to hit around USD 49.13 billion by 2035, increasing from USD 22.96 billion in 2025, with a CAGR of 7.90%.
September 2026
The artificial intelligence in diagnostics market size was calculated at USD 2.33 billion in 2026 and is projected to hit around USD 11.82 billion by 2035 with a CAGR of 19.81%.
September 2026
The global in vitro diagnostics (IVD) market size accounted for USD 106.16 billion in 2026 and is expected to reach USD 135.76 billion by 2035.
September 2026
The global cancer diagnostics market size was exhibited at USD 184.96 billion in 2026 and is predicted to surpass around USD 378.44 billion by 2035 with a CAGR of 8.33%.
September 2026
The global paper diagnostics market size is expected to increase from USD 19.65 billion in 2026 and is expected to attain around USD 31.80 billion by 2034 with a CAGR of 6.20%.
September 2026
The global Alzheimers disease diagnostics market size was evaluated at USD 10.42 billion in 2026 and is predicted to hit around USD 26.21 billion by 2035, growing at a CAGR of 10.80%.
September 2026
The global blood transfusion diagnostics market size was evaluated at USD 5.58 billion in 2026 and is predicted to hit around USD 8.79 billion by 2034, growing at a CAGR of 5.84%.
September 2026
The global syphilis immunoassay diagnostics market size is estimated to hit around USD 992.65 million by 2034 from USD 644.85 million in 2026, with a CAGR of 5.54%.
September 2026
The infectious respiratory disease diagnostics market size was USD 60.62 billion in 2026, with leading infectious respiratory disease diagnostics market players including F. Hoffmann - La Roche, Thermo Fisher Scientific, Danaher (Cepheid), Abbott LaboratoriesÂ
August 2026
The us in vitro diagnostics market reached USD 35.94 billion in 2026, featuring leading us in vitro diagnostics companies such as alere inc, Beckman coulter, bd, Danaher, Bio-Rad laboratories.
August 2026
The homecare diagnostics & therapeutics market size accounted for USD 269.92 billion in 2025 and is expected to hit USD 577.56 billion by 2035, with a CAGR of 7.90%.
August 2026
The breast cancer diagnostics market size is valued at USD 20.14 billion in 2025 and is projected to hit around USD 43.62 billion by 2035 with a CAGR of 8.03%.
August 2026
The global home diagnostics market size accounted for USD 6.91 billion in 2025 and is expected to reach USD 11.54 billion by 2035, growing at a CAGR of 5.26%.
August 2026
The global tissue diagnostics market size is expected to increase from USD 5.77 billion in 2025 and is projected to hit around USD 10.99 billion by 2035 with a CAGR of 6.66%
August 2026
The molecular diagnostics market size is calculated at USD 45.11 billion in 2025 and is expected to hit around USD 66.34 billion by 2035 with a CAGR of 3.93%.
July 2026
The global point-of-care diagnostics market size is exhibited at USD 64.08 billion in 2025 and is predicted to be worth around USD 85.03 billion by 2035 with a CAGR of 2.87%.
July 2026
The U.S. oncology molecular diagnostics market size is projected to surge USD 2,740 million by 2035 from USD 880 million in 2025 with a notable CAGR of 12.03%.
July 2026
The global blood cancer diagnostics market size is estimated to hit around USD 22.55 billion by 2035 increasing from USD 11.65 billion in 2025, with a CAGR of 6.83%.
July 2026
The global point-of-care molecular diagnostics market size was valued at USD 8.95 billion in 2025 and is expected to hit around USD 13.06 billion by 2035, at a CAGR of 3.85%.
July 2026
The U.S. tuberculosis diagnostics market size was evaluated at USD 576.00 million in 2025 and is predicted to hit around USD 968.67 million by 2035, growing at a CAGR of 5.34%.
July 2026
The global in vitro diagnostics quality controls market size is estimated to hit around USD 2,713.92 million by 2035, increasing from USD 1,736.17Â million in 2026, with a CAGR of 5.09%.
June 2026
The global veterinary point of care diagnostics market size is estimated to hit around USD 7.87 billion by 2035 from USD 2.96 billion in 2025, with a CAGR of 10.27%.
June 2026
The global preeclampsia diagnostics market size is evaluated at USD 1.29 billion in 2025 and is predicted to hit around USD 1.75 billion by 2035, growing at a CAGR of 3.10%.
June 2026
The global CRISPR-based diagnostics market size is evaluated at USD 3.79 billion in 2025 and is predicted to hit around USD 17.09 billion by 2035, growing at a CAGR of 16.25%.
June 2026
The rapid diagnostics market size was estimated at USD 51.12 billion in 2025 and is projected to surpass around USD 322.71 billion in 2035 with a solid CAGR of 20.23%.
June 2026
The global bladder cancer therapeutics diagnostics market size was valued at USD 5.68 billion in 2025 and is expected to hit around USD 10.04 billion by 2035, growing at a CAGR of 5.86%.
June 2026
The global guillain barre syndrome diagnostics market size is estimated to hit around USD 206.70 million by 2035 increasing from USD 154.02 million in 2025, with a CAGR of 2.99%.
+1 650 460 3308
+61 485 981 310 +91 87933 22019
sales@precedenceresearch.com